• 7028 malaria professionals are enjoying the free benefits of MalariaWorld today

pharmacogenetics

Viewpoint: The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics

Author(s): 
The Lancet, Volume 376, Issue 9742, 28 August 2010-3 September 2010, Pages 739-741
Reference: 
Lucio Luzzatto
Contact email: 
lucio.luzzatto@ittumori.it

"Although artemisinin and related compounds have been promising therapies since the 1980s, their low availability and high cost have greatly delayed large-scale use."  "Therefore, in the late 1990s, a combination of chlorproguanil (Lapudrine) and dapsone—both low-cost drugs—known as Lapdap was introduced."

Syndicate content